{"lastClose": 1.25, "len": 477, "date": "2023-03-09", "alpha_1": -0.5548242264654921, "beta_1": 2.5565376866924554, "drawup_1": 0.6999999674883763, "natr_1": 37.18556327628612, "res_1": 0.8160000165303547, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 37.1559650084655, "adx_1": 23.230206243579733, "drawdown_1": -0.727668854369158, "stratHoldSharpe_1": -0.5353479765069974, "stratHoldAlpha_1": 250.5260566572437, "stratHoldDrawdown_1": -0.6712818318941531, "alpha_3mo": -0.44990023771408805, "beta_3mo": 2.4154835783101025, "drawup_3mo": 0.44078952940877514, "natr_3mo": 37.18556327628612, "sup_3mo": -0.03733329772949219, "res_3mo": 0.3813333511352539, "bullPattern_3mo": [], "bearPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_3mo": 15.068494716579107, "adx_3mo": 91.31689735944376, "drawdown_3mo": -0.42922375920551525, "stratHoldSharpe_3mo": -1.7792126595914388, "stratHoldAlpha_3mo": 249.7225850345134, "stratHoldDrawdown_3mo": -0.3918480924065335, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "Country": "United States", "Market Cap": 2587333929, "sup_1": -0.18399995168050154, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2021.0, "alpha%_1": 0.05179231644625409, "beta%_1": 0.999026783624262, "drawup%_1": 0.655134739012661, "natr%_1": 1.0, "drawdown%_1": 0.03372559540485716, "stratHoldSharpe%_1": 0.21169601048954206, "stratHoldAlpha%_1": 0.02863604527031642, "stratHoldDrawdown%_1": 0.03137060368257958, "alpha%_3mo": 0.14351137160794564, "beta%_3mo": 0.9945673539605002, "drawup%_3mo": 0.8702667815306957, "natr%_3mo": 1.0, "drawdown%_3mo": 0.000682158563211171, "stratHoldSharpe%_3mo": 0.11086553291754997, "stratHoldAlpha%_3mo": 0.006789252727066287, "stratHoldDrawdown%_3mo": 0.0007000984276993544}